MTATP6P4

Across TCGA pan-cancer cohorts, MTATP6P4 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of MTATP6P4’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where MTATP6P4 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MTATP6P4 is over-expressed in tumor.

STAD and BRCA are the cancer types where MTATP6P4 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MTATP6P4 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	All	III,IV	+0.087	.008	4	view →
BRCA	All	II,III,IV	+0.012	.014	4	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

MTATP6P4–STAD

Open the STAD breakdown →